RightFit
Not yet recruitingNot applicable

Dyadic Life Review Intervention for Older Patients With Advanced Cancer and Alzheimer's Disease and Related Dementias and Their Caregivers

A Randomized Controlled Trial (RCT) of a Dyadic Life Review Intervention for Older Patients With Advanced Cancer and Alzheimer's Disease and Related Dementias (ADRD) and Their Caregivers

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
50 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests whether Dyadic Life Review (DLR) therapy can reduce the strain of caregiving. It is for adults age 65 or older with advanced cancer and problems with memory or thinking, and their caregivers.

The purpose of this study is to evaluate the efficacy of Dyadic Life Review (DLR) therapy for reducing caregiver distress, measured by caregiver burden to capture the multifaceted experience of distress, among older adults with advanced cancer and cognitive impairment and their caregivers.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Patients must be age 65 or older and have stage III or IV cancer of any type.
  • Patients must score at least 15 on the MoCA, a test of memory and thinking, given in person or by phone.
  • Patients must score at least 5 on the Katz test of daily tasks, such as dressing and bathing.
  • Patients and caregivers must be able to read and understand English.
  • Patients must be able to give informed consent (agree to join after learning about the study), as checked by the UBACC test, or have a legally approved person agree for them. This person may be the caregiver.
  • Caregivers must be age 50 or older.
  • Caregivers must be a spouse, romantic partner, significant other, or adult child whom the patient talks with about health or who can help with health matters.
  • Caregivers must score at least 5 on the Modified Caregiver Strain Index, a measure of caregiving strain.

Who can't join

  • Patients cannot join if no caregiver is willing to take part.
  • Caregivers cannot join if they cannot give informed consent.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Age ≥65 * Stage III or IV cancer diagnosis, of any type * The Montreal Cognitive Assessment (MoCA) in-person or MoCA-telephone version ≥15 * Katz Activities of Daily Living (ADL) ≥5 * Able to read and understand English * Be able to provide informed consent (as measured by UBACC) or have a Legally Authorized Representative to provide informed consent, which can include the participating caregiver. Caregiver Inclusion Criteria: * Age 50 or older * Caregivers are defined is a "significant other, spouse, romantic partner, or adult child with whom you discuss or who can be helpful in health-related matters;" * Modified Caregiver Strain Index ≥ 5 * Able to read and understand English Patient Exclusion Criteria: * No caregiver willing to participate in the study Caregiver Exclusion Criteria: • Caregivers unable to provide consent

Study sites (1)

NY